A novel possible familial cause of epilepsy of infancy with migrating focal seizures related to SZT2 gene variant

dc.contributor.authorEl Halabi, Tarek
dc.contributor.authorDirani, Maya M.
dc.contributor.authorHotait, Mostafa
dc.contributor.authorNasreddine, Wassim M.
dc.contributor.authorBeydoun, Ahmad A.
dc.contributor.departmentNeurology
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T12:07:40Z
dc.date.available2025-01-24T12:07:40Z
dc.date.issued2021
dc.description.abstractSeizure threshold-2 (SZT2) gene variants have been associated with a decrease in seizure threshold resulting in variable phenotypic expressions ranging from mild-moderate intellectual disabilities without seizures, to an early-onset epileptic encephalopathy with severe cognitive impairment. In addition, hypotonia and distinctive facial dysmorphism, including a high forehead and to a lesser extent ptosis and down-slanting palpebral fissures, were present in the majority. We herein report a novel SZT2 variant in one of two siblings both diagnosed with epilepsy of infancy with migrating focal seizures (EIMFS). This report is the fourth to document a possible familial case in EIMFS, a condition that was not previously associated with SZT2 variant. This report expands the phenotypic expression of SZT2, corroborates the importance of genetic counseling in some cases of EIMFS, and highlights the efficacy of potassium bromide in controlling the seizures associated with this condition. © 2020 The Authors. Epilepsia Open published by Wiley Periodicals LLC on behalf of International League Against Epilepsy
dc.identifier.doihttps://doi.org/10.1002/epi4.12451
dc.identifier.eid2-s2.0-85099027320
dc.identifier.urihttp://hdl.handle.net/10938/31601
dc.language.isoen
dc.publisherBlackwell Publishing Ltd
dc.relation.ispartofEpilepsia Open
dc.sourceScopus
dc.subjectFamilial epilepsy of infancy with migrating focal seizures
dc.subjectInfantile epileptic encephalopathy
dc.subjectPotassium bromide
dc.subjectSzt2
dc.subjectBiotin
dc.subjectClonazepam
dc.subjectFolinic acid
dc.subjectImmunoglobulin m
dc.subjectLacosamide
dc.subjectLevetiracetam
dc.subjectPhenobarbital
dc.subjectPyridoxine
dc.subjectValproate calcium
dc.subjectAdd on therapy
dc.subjectApnea
dc.subjectArticle
dc.subjectAuditory system function
dc.subjectBehavior disorder
dc.subjectBlinking
dc.subjectCardiopulmonary insufficiency
dc.subjectCorpus callosum
dc.subjectCyanosis
dc.subjectDisease duration
dc.subjectDrug dose titration
dc.subjectElectroencephalography
dc.subjectEpilepsy
dc.subjectFace dysmorphia
dc.subjectFemale
dc.subjectFlushing
dc.subjectFocal epilepsy
dc.subjectGene
dc.subjectGenetic variability
dc.subjectHomozygosity
dc.subjectHypsarrhythmia
dc.subjectIncreased tone
dc.subjectInfant
dc.subjectInfantile spasm
dc.subjectLennox gastaut syndrome
dc.subjectMuscle hypotonia
dc.subjectNewborn
dc.subjectNuclear magnetic resonance spectroscopy
dc.subjectOxygen saturation
dc.subjectPalpebral fissure
dc.subjectPregnancy
dc.subjectSeizure threshold
dc.subjectSepsis
dc.subjectSeptum pellucidum
dc.subjectSzt2 gene
dc.titleA novel possible familial cause of epilepsy of infancy with migrating focal seizures related to SZT2 gene variant
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2021-2605.pdf
Size:
674.18 KB
Format:
Adobe Portable Document Format

Collections